LEADER 04650nam 2201465z- 450 001 9910585935503321 005 20231214132947.0 035 $a(CKB)5600000000483130 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/91208 035 $a(EXLCZ)995600000000483130 100 $a20202208d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAdvances in Antifungal Development: Discovery of New Drugs and Drug Repurposing 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 electronic resource (282 p.) 311 $a3-0365-4768-1 311 $a3-0365-4767-3 330 $aThis reprint describes recent advances made in the field of antifungal development, especially the discovery of new drugs and drug repurposing. The articles presented in this book provide useful information and insight for the development of new antifungal drugs or intervention strategies. The identification of new, safe molecules, and cellular targets, as well as the elucidation of their antifungal mechanisms of action, will further the effective control of fungal pathogens, especially those resistant to current therapeutic agents. 517 $aAdvances in Antifungal Development 606 $aResearch & information: general$2bicssc 606 $aBiology, life sciences$2bicssc 610 $ananoparticles 610 $afungi 610 $adrug delivery systems 610 $amarine 610 $abiological synthesis 610 $amyconanotechnology 610 $acanesten 610 $aclotrimazole 610 $avulvovaginal 610 $avaginitis 610 $amycosis 610 $acandidosis 610 $ayeast infection 610 $acandida 610 $acandida albicans 610 $avaginal health 610 $aanticandidal activity 610 $aindazole 610 $apyrazole 610 $a3-phenyl-1H-indazole 610 $adrug design 610 $aacetylsalicylic acid (ASA, aspirin) 610 $acapsule 610 $aCAP64 610 $aCryptococcus 610 $amembrane potential (??M) 610 $aphotodynamic treatment 610 $aphotosensitiser 610 $aultrastructure 610 $adrug repurposing 610 $aantifungals 610 $arepositioning 610 $ayeasts 610 $aemerging fungi 610 $amultidrug resistance 610 $atherapeutic alternatives 610 $anew targets 610 $aCandida auris 610 $aAspergillus spp. 610 $aantifungal 610 $abeta-glucan 610 $apolycations 610 $aGalleria mellonella model 610 $aretinoids 610 $aCandida spp. 610 $aonychomycosis 610 $aMalassezia spp. 610 $adermatophytes 610 $amicrobiology 610 $amycology 610 $aall-trans retinoic acid 610 $aAcanthamoeba 610 $afree-living ameba 610 $aAcanthamoeba keratitis 610 $aisavuconazonium sulfate 610 $acyst 610 $adrug 610 $adrug discovery 610 $adrug targets 610 $ainvasive aspergillosis treatment 610 $ainvasive fungal infections 610 $afission yeast 610 $acell wall 610 $a?(1,3)-D-glucan synthase 610 $aantifungal drugs 610 $aechinocandin drugs 610 $aechinocandin resistance 610 $aFks resistance hot spots 610 $acytokinesis 610 $aseptation 610 $acell separation 610 $acell integrity 610 $acell lysis 610 $asporotrichosis 610 $aFelis catus 610 $aquinones 610 $ahydrazones 610 $azoonoses 610 $ahost-directed drug therapy 610 $aazoles 610 $apolyenes 610 $aechinocandins 610 $aviral infections 610 $aazole 610 $asynergy 610 $aresistance 610 $aCandida 610 $anatural products 615 7$aResearch & information: general 615 7$aBiology, life sciences 700 $aKim$b Jong Heon$4edt$01318507 702 $aCheng$b Luisa W$4edt 702 $aLand$b Kirkwood$4edt 702 $aKim$b Jong Heon$4oth 702 $aCheng$b Luisa W$4oth 702 $aLand$b Kirkwood$4oth 906 $aBOOK 912 $a9910585935503321 996 $aAdvances in Antifungal Development: Discovery of New Drugs and Drug Repurposing$93033342 997 $aUNINA